$56.52
2.63% yesterday
Nasdaq, Oct 15, 10:00 pm CET

Lantheus Holdings Inc Stock price

$56.52
+4.78 9.24% 1M
-46.26 45.01% 6M
-32.94 36.82% YTD
-55.44 49.52% 1Y
-15.07 21.05% 3Y
+43.27 326.57% 5Y
+52.66 1,364.25% 10Y
+49.75 734.86% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
+1.45 2.63%

Key metrics

Basic
Market capitalization
$3.8b
Enterprise Value
$3.7b
Net debt
positive
Cash
$695.6m
Shares outstanding
68.0m
Valuation (TTM | estimate)
P/E
14.7 | 9.7
P/S
2.5 | 2.5
EV/Sales
2.4 | 2.5
EV/FCF
7.8
P/B
3.3
Financial Health
Equity Ratio
54.9%
Return on Equity
28.7%
ROCE
23.8%
ROIC
23.5%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$1.5b | $1.5b
EBITDA
$498.9m | $569.8m
EBIT
$437.6m | $552.3m
Net Income
$271.0m | $394.7m
Free Cash Flow
$478.6m
Growth (TTM | estimate)
Revenue
5.8% | -1.4%
EBITDA
-2.7% | 11.0%
EBIT
-3.4% | 23.1%
Net Income
-36.8% | 26.3%
Free Cash Flow
48.8%
Margin (TTM | estimate)
Gross
63.8%
EBITDA
32.8% | 37.7%
EBIT
28.8%
Net
17.8% | 26.1%
Free Cash Flow
31.5%
More
EPS
$3.9
FCF per Share
$7.0
Short interest
14.0%
Employees
808
Rev per Employee
$1.9m
Show more

Is Lantheus Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Lantheus Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Lantheus Holdings Inc forecast:

16x Buy
84%
3x Hold
16%

Analyst Opinions

19 Analysts have issued a Lantheus Holdings Inc forecast:

Buy
84%
Hold
16%

Financial data from Lantheus Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,521 1,521
6% 6%
100%
- Direct Costs 551 551
8% 8%
36%
969 969
5% 5%
64%
- Selling and Administrative Expenses 393 393
17% 17%
26%
- Research and Development Expense 141 141
1% 1%
9%
499 499
3% 3%
33%
- Depreciation and Amortization 61 61
2% 2%
4%
EBIT (Operating Income) EBIT 438 438
3% 3%
29%
Net Profit 271 271
37% 37%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Lantheus Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lantheus Holdings Inc Stock News

Neutral
PRNewsWire
about 11 hours ago
NEW YORK , Oct. 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important November 10, 2025 lead plaintiff deadline. So what: If you purchased Lantheus securities during the Class Period you ma...
Neutral
GlobeNewsWire
about 14 hours ago
The lawsuit alleges Lantheus misled investors about Pylarify's pricing and competition, hiding risks that hurt its growth, revenue, and market position.
Neutral
PRNewsWire
about 15 hours ago
LOS ANGELES , Oct. 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). IF YOU SUFFERED A LOSS ON YOUR LANTHEUS INVESTMENTS, CLICK HERE BEFORE NOVEMBER 10, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURI...
More Lantheus Holdings Inc News

Company Profile

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Head office United States
CEO Brian Markison
Employees 808
Founded 1956
Website www.lantheus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today